QDEL - Quidel more quick diagnosis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QDEL - Quidel more quick diagnosis

QDEL 28.12

+5.7%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert Busse who wrote (408)	2/19/1997 12:25:00 AM
From: Mike Relyea	of 1693

A 17 February 1997 Reuters article "Empiric Antibiotics Most Cost-Effective For Dyspepsia, H. Pylori" lends credence to the view that the market for Quidel's H.pylori test is much larger than just testing people with ulcers. reutershealth.com In the article it's said that Doctors recommend testing dyspepsia patients for H.pylori (using a test like Quidel's) and treating those who are positive. I remember reading somewhere that about five percent of doctor visits are for dyspepsia. If five percent of all patients who visit the doctor are eventually tested for H.pylori, Quidel's sure to sell one big bunch of tests. Mike

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next